MedTrace Logo

Efficacy and Tolerability of SkinPen on Male and Female Subjects' Wrinkles of the Neck

NCT03803059 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2021-12-01

Study results available
· View outcomes & findings →

Summary

This single-center, the clinical trial is being conducted over the course of 90 days followed by 1-month and 6-month post-treatment visits in order to assess the efficacy and tolerability of the Sponsor's SkinPen device when used by men and women with the wrinkles of the neck.

Conditions

  • Wrinkles

Interventions

DEVICE

SkinPen Precision

Surgical instrument motors and accessories/attachments/Hydrogel

Sponsors & Collaborators

  • Bellus Medical, LLC

    lead INDUSTRY

Principal Investigators

  • Jeffrey Kenkel, MD · University of Texas Southwestern Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-31
Primary Completion
2020-01-10
Completion
2020-01-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03803059 on ClinicalTrials.gov